News | July 01, 2022
H Clinical adds commercial home health capabilities for pharma industry
H Clinical is the leader in decentralized clinical trial support and home visits in Latin America
H Clinical is the leader in decentralized clinical trial support and home visits in Latin America
We must try to make the health care system more accessible for people with disabilities
Bringing next-gen cannabinoid therapeutics to cancer patients
Site has a capital investment program of ~$30 million spent or committed over the last three years to expand capabilities and improve operational efficiencies
The new program includes upstream and downstream process development and large-scale GMP production.
Cantourage introduces second Clever Leaves medical cannabis product to the German market
This MoU will further strengthen relations between India and the USA within the framework of international scientific and technological cooperation in fields of mutual interest.
Norliqva was approved by the FDA on February 24, 2022 and is now available through normal retail distribution.
Evrysdi has proven efficacy in babies, children and adults with more than 5,000 patients treated to date
By 2025, the company plans to achieve carbon and water neutrality, zero-waste to landfill, anti-microbial resistance stewardship and green chemistry
Subscribe To Our Newsletter & Stay Updated
